N-[5-[1-(3,4-dimethylphenyl)-5-oxopyrrolidin-3-yl]-1,3,4-thiadiazol-2-yl]-4-(1,3-dioxoisoindol-2-yl)benzamide

C29H23N5O4S — CID 17204373

IUPACN-[5-[1-(3,4-dimethylphenyl)-5-oxopyrrolidin-3-yl]-1,3,4-thiadiazol-2-yl]-4-(1,3-dioxoisoindol-2-yl)benzamide
SMILESCc1ccc(N2CC(c3nnc(NC(=O)c4ccc(N5C(=O)c6ccccc6C5=O)cc4)s3)CC2=O)cc1C
InChIInChI=1S/C29H23N5O4S/c1-16-7-10-21(13-17(16)2)33-15-19(14-24(33)35)26-31-32-29(39-26)30-25(36)18-8-11-20(12-9-18)34-27(37)22-5-3-4-6-23(22)28(34)38/h3-13,19H,14-15H2,1-2H3,(H,30,32,36)
InChIKeyAHFDSQNXBIBVFF-UHFFFAOYSA-N
MW537.60 g/mol
LogP4.73
Rot. Bonds5

About N-[5-[1-(3,4-dimethylphenyl)-5-oxopyrrolidin-3-yl]-1,3,4-thiadiazol-2-yl]-4-(1,3-dioxoisoindol-2-yl)benzamide

N-[5-[1-(3,4-dimethylphenyl)-5-oxopyrrolidin-3-yl]-1,3,4-thiadiazol-2-yl]-4-(1,3-dioxoisoindol-2-yl)benzamide (PubChem CID 17204373) has the molecular formula C29H23N5O4S and a molecular weight of 537.60 g/mol. Its IUPAC name is N-[5-[1-(3,4-dimethylphenyl)-5-oxopyrrolidin-3-yl]-1,3,4-thiadiazol-2-yl]-4-(1,3-dioxoisoindol-2-yl)benzamide.

Molecular Properties

Compound NameN-[5-[1-(3,4-dimethylphenyl)-5-oxopyrrolidin-3-yl]-1,3,4-thiadiazol-2-yl]-4-(1,3-dioxoisoindol-2-yl)benzamide
PubChem CID17204373
Molecular FormulaC29H23N5O4S
Molecular Weight537.60 g/mol
Exact Mass537.15
IUPAC NameN-[5-[1-(3,4-dimethylphenyl)-5-oxopyrrolidin-3-yl]-1,3,4-thiadiazol-2-yl]-4-(1,3-dioxoisoindol-2-yl)benzamide
SMILESCc1ccc(N2CC(c3nnc(NC(=O)c4ccc(N5C(=O)c6ccccc6C5=O)cc4)s3)CC2=O)cc1C
InChIInChI=1S/C29H23N5O4S/c1-16-7-10-21(13-17(16)2)33-15-19(14-24(33)35)26-31-32-29(39-26)30-25(36)18-8-11-20(12-9-18)34-27(37)22-5-3-4-6-23(22)28(34)38/h3-13,19H,14-15H2,1-2H3,(H,30,32,36)
InChIKeyAHFDSQNXBIBVFF-UHFFFAOYSA-N
XLogP4.73
TPSA112.57 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds5
Heavy Atoms39
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500537.60
LogP ≤ 54.73
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze N-[5-[1-(3,4-dimethylphenyl)-5-oxopyrrolidin-3-yl]-1,3,4-thiadiazol-2-yl]-4-(1,3-dioxoisoindol-2-yl)benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[5-[1-(3,4-dimethylphenyl)-5-oxopyrrolidin-3-yl]-1,3,4-thiadiazol-2-yl]-4-(1,3-dioxoisoindol-2-yl)benzamide?
The IUPAC name of N-[5-[1-(3,4-dimethylphenyl)-5-oxopyrrolidin-3-yl]-1,3,4-thiadiazol-2-yl]-4-(1,3-dioxoisoindol-2-yl)benzamide (CID 17204373) is N-[5-[1-(3,4-dimethylphenyl)-5-oxopyrrolidin-3-yl]-1,3,4-thiadiazol-2-yl]-4-(1,3-dioxoisoindol-2-yl)benzamide.
What is the SMILES notation for N-[5-[1-(3,4-dimethylphenyl)-5-oxopyrrolidin-3-yl]-1,3,4-thiadiazol-2-yl]-4-(1,3-dioxoisoindol-2-yl)benzamide?
The canonical SMILES for N-[5-[1-(3,4-dimethylphenyl)-5-oxopyrrolidin-3-yl]-1,3,4-thiadiazol-2-yl]-4-(1,3-dioxoisoindol-2-yl)benzamide is Cc1ccc(N2CC(c3nnc(NC(=O)c4ccc(N5C(=O)c6ccccc6C5=O)cc4)s3)CC2=O)cc1C.
What is the InChIKey of N-[5-[1-(3,4-dimethylphenyl)-5-oxopyrrolidin-3-yl]-1,3,4-thiadiazol-2-yl]-4-(1,3-dioxoisoindol-2-yl)benzamide?
The InChIKey is AHFDSQNXBIBVFF-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H23N5O4S/c1-16-7-10-21(13-17(16)2)33-15-19(14-24(33)35)26-31-32-29(39-26)30-25(36)18-8-11-20(12-9-18)34-27(37)22-5-3-4-6-23(22)28(34)38/h3-13,19H,14-15H2,1-2H3,(H,30,32,36).
What are the key properties of N-[5-[1-(3,4-dimethylphenyl)-5-oxopyrrolidin-3-yl]-1,3,4-thiadiazol-2-yl]-4-(1,3-dioxoisoindol-2-yl)benzamide?
N-[5-[1-(3,4-dimethylphenyl)-5-oxopyrrolidin-3-yl]-1,3,4-thiadiazol-2-yl]-4-(1,3-dioxoisoindol-2-yl)benzamide has a molecular weight of 537.60 g/mol, XLogP of 4.73, 5 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-[5-[1-(3,4-dimethylphenyl)-5-oxopyrrolidin-3-yl]-1,3,4-thiadiazol-2-yl]-4-(1,3-dioxoisoindol-2-yl)benzamide is sourced from PubChem (CID 17204373), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).